Suraj K. George - Concepedia

Author

Suraj K. George

The University of Texas MD Anderson Cancer Center

Also Known As

Konnath George, S., Suraj K George, Suraj K. George, Suraj Konnath George

Publications

639

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Regional Cancer Center, Thiruvananthapuram University of Kerala East China University of Science and Technology Quest International University Perak

About

Suraj K. George is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	356
2	Engineering	2	2	56
3	Cell Biology	2	2	91
4	Biomedical Engineering	1	1	28
5	Biomolecular Engineering	1	1	28

Suraj K. George

Publications

547

Citations

H-Index

Page 1

	Year	Citations
A galactomannan polysaccharide from Punica granatum imparts in vitro and in vivo anticancer activity Manu M. Joseph, S.R. Aravind, Suraj K. George, Carbohydrate Polymers Vivo Anticancer ActivityPunica Granatum ImpartsMedicineGlycobiologyPathology	2013	106
Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44+/Musashi-1+ gastric cancer stem cells Min Xu, Aihua Gong, Hongqiong Yang, Cancer Letters Oncogene Homolog 1Enhances Drug ResistanceDevelopmental BiologySonic Hedgehog-gliomaGlioma	2015	66
Galactoxyloglucan-Modified Nanocarriers of Doxorubicin for Improved Tumor-Targeted Drug Delivery with Minimal Toxicity Manu M. Joseph, S.R. Aravind, Suraj K. George, Journal of Biomedical Nanotechnology NanomedicineDrug TargetingLower Ld50Pst-dox NanoparticlesMedicine	2014	54
Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen Suraj K. George, Veronica Tovar-Sepulveda, Steven S. Shen, Translational Oncology	2013	45
Antitumor activity of galactoxyloglucan-gold nanoparticles against murine ascites and solid carcinoma Manu M. Joseph, S.R. Aravind, Suraj K. George, Colloids and Surfaces B Biointerfaces NanomedicineNanotherapeuticsAntitumor ActivityTherapeutic NanomaterialsMedicine	2014	33
Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs Jennifer Mitchell, Peggy T. Tinkey, Rony Avritscher, Oncology	2016	32
The ALK inhibitor ASP3026 eradicates NPM-ALK+ T-cell anaplastic large-cell lymphoma <i>in vitro</i> and in a systemic xenograft lymphoma model Suraj K. George, Deeksha Vishwamitra, Roxsan Manshouri, Oncotarget	2014	28
Co-Encapsulation of Doxorubicin With Galactoxyloglucan Nanoparticles for Intracellular Tumor-Targeted Delivery in Murine Ascites and Solid Tumors Manu M. Joseph, S.R. Aravind, Suraj K. George, Translational Oncology NanomedicineOncologyEngineeringPolymer-drug ConjugateMedicine	2014	28
Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis Manu M. Joseph, S.R. Aravind, Suraj K. George, European Journal of Pharmaceutics and Biopharmaceutics NanomedicineEngineeringProtein NanoparticlesPolymer-drug ConjugateMedicine	2015	28
Downregulation of MicroRNA-152 contributes to high expression of DKK1 in multiple myeloma Yinyin Xu, Bingda Chen, Suraj K. George, RNA Biology	2015	28

Page 1